Welcome to DukeHealth.org.
Skip over navigation
  • Home
  • Services
  • Locations
  • Physicians
  • Patient and Visitor Info
  • Clinical Trials
  • Event Calendar
  • Health Library
  • About Duke Medicine

Quick Links

  • Appointments
  • HealthView Patient Login
  • Quality and Safety
Home > Physicians > Onken, Jane E.
Jumbo Large Regular Text:
Print E-mail
Physicians

Jane E. Onken, MD, MHS

Related Content

Services

  • Colon, Rectal, and Anal Disorders
  • Colonoscopy
  • Gastric (Stomach) Disorders
  • Small Intestine and Appendix Disorders
  • Upper Endoscopy

Share

Jane E. Onken, MD, MHS

Department / Division
Medicine / Medicine - Gastroenterology

Address
DUMC 3902
Durham, NC 27710

Appointment Telephone
919-684-6437

Office Telephone
919-684-1817

Fax Telephone
919-681-8147

Training
  • MD, George Washington University School of Medicine and Health Sciences (Washington, DC), 1987

Residency
  • Internal Medicine, Duke University Medical Center, 1987-1990

Fellowship
  • Gastroenterology, Duke University Medical Center, 1990-1993

Other Training
  • MHS, Duke University, 2005

Clinical Interests
Inflammatory bowel disease, diagnostic and therapeutic endoscopy, GI bleeding, clinical research

Industry Relationships and Collaborations (What's this?)

This physician (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

  • Abbott Laboratories
  • Bristol-Myers Squibb
  • Centocor, Inc. (Johnson & Johnson)
  • GlaxoSmithKline
  • Luitpold Pharmaceuticals, Inc (Daiichi Sankyo Co)
  • Marathon
  • Pfizer Inc.
  • Schering-Plough Corp. (owned by Merck & Co, USA)

Representative Publications
Provenzale D, Onken JE. TPMT genotype screening for patients about to begin azathioprine treatment--a look at costs and potential benefits. Inflamm Bowel Dis. 2005 Dec;11(12):1119-20. (2005) Abstract

Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med. 2004 Feb 26;350(9):876-85. (2004) Abstract

Bloomfeld RS, Onken JE. Mercaptopurine metabolite results in clinical gastroenterology practice. Aliment Pharmacol Ther. 2003 Jan;17(1):69-73. (2003) Abstract

Onken JE, Friedman JY, Subramanian S, Weinfurt KP, Reed SD, Malenbaum JH, Schmidt T, Schulman KA. Treatment patterns and costs associated with sessile colorectal polyps. Am J Gastroenterol. 2002 Nov;97(11):2896-901. (2002) Abstract

Eloubeidi MA, Onken JE. Manifestations of Crohn's disease. Dig Dis. 1998 Jul-Aug;16(4):262. (1998) Abstract

Provenzale D, Wong JB, Onken JE, Lipscomb J. Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis. Am J Gastroenterol. 1998 Jun;93(6):872-80. (1998) Abstract

Contact Us | Careers | Privacy Policy | Make a Gift | Site Map | RSS Feeds | En EspaƱol | Mobile Site | Help
Duke Medicine | Duke School of Medicine | Duke Children's | Duke University
Toll-Free: 888-ASK-DUKE (888-275-3853)
Copyright © 2004-2012 Duke University Health System

About This Page

Updated: Dec. 12, 2006
Published: Dec. 12, 2006
URL: http://www.dukehealth.org/physicians/jane_e_onken